Company News

FEATURED POST

February 11, 2021

MyoStrain® Provides Comprehensive Assessment of Myocardial Deformation to Help Physicians Risk-Stratify Heart Failure Patients for Individualized Cardiac Treatment

A new article published in the European Society of Cardiology (ESC) Heart Failure Journal demonstrated MyoStrain’s ability to accurately detect and delineate patterns of myocardial dysfunction between heart failure (HF) types and severity...

Read more >

June 23, 2020

Myocardial Solutions Announces New CMS Codes Dedicated to Proprietary MyoStrain® and MyoStress™ Testing

Myocardial Solutions, Inc. (MSI), who has pioneered the quantification of segmental cardiac strain testing to transform how physicians manage and monitor patient heart health, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued unique codes for MSI’s...

Read more >
Blurred light stretches along windy, mountainous road

May 28, 2020

Myocardial Solutions Named Top 50 Most Innovative Companies to Watch in 2020

Myocardial Solutions, Inc. (MSI) was recognized in an article published by the CEO Views describing their selection for the “Most Innovative Companies to Watch in 2020” yearly list. The list highlights companies driving innovative technology solutions to challenge and transform the current ...

Read more >
A physician types on a laptop

April 25, 2020

New ESC Webinar Highlights MyoStrain® Cardio-Oncology Solution for the Early Detection & Management of Cancer Patient Cardiotoxicity

MyoStrain® was featured in the European Society of Cardiology’s (ESC) cardio-oncology webinar series to examine the role of MyoStrain in helping cardio-oncologists manage cardiac health for patients undergoing cancer therapy. As part of an educational grant sponsored by Myocardial Solutions...

Read more >
3d human heart and arteries mold

March 31, 2020

Six Abstracts Featuring MyoStrain Published at American College of Cardiology 2020 Scientific Sessions

Six new abstracts & posters showcasing MyoStrain were published as part of the American College of Cardiology’s (ACC) 69th Annual Scientific Session & Expo. The conference, which was scheduled to take place in Chicago, Illinois from March 28-30, was shifted to a virtual experience due to the...

Read more >
handheld digital heart model floating in hand

February 18, 2020

Sixteen MyoStrain Abstracts, Posters & Podium Presentations Presented at SCMR 2020

Myocardial Solutions (MSI) enabled 16 new abstracts and five podium presentations showcasing the latest in MyoStrain insights to the Society for Cardiovascular Magnetic Resonance’s (SCMR) 23rd Annual Scientific...

Read more >
chemotherapy treatment dripping from syringe

October 11, 2019

New Abstract: Utilizing MyoStrain to Detect Cardiotoxic Effects of Carfilzomib

A newly submitted clinical abstract utilizes MyoStrain to detect the cardiotoxic effects of Carfilzomib, a cancer therapy drug used in treating patients diagnosed with multiple myeloma.Conducted at Heidelberg University Hospital in Germany as part of an ongoing...

Read more >
digital human model displaying internal organs

September 5, 2019

Eight New MyoStrain Posters and Presentations Presented at ESC Congress in Paris 2019

Last weekend, the Myocardial Solutions (MSI) team attended the European Society of Cardiology (ESC) Congress 2019 to further the discussion of MyoStrain as a unique clinical tool for helping physicians proactively detect, monitor and manage heart failure. The ESC Congress took place from August...

Read more >
young medical professionals excited for learning

August 21, 2019

New Publication Evaluates the Effects of Experience & Training on MyoStrain Reproducibility

A new article on MyoStrain has been published in Nature Research’s recent Scientific Reports issue. Based upon an ongoing study conducted at German Heart Center Berlin (Charité University Medical Center Berlin), the article evaluates MyoStrain’s consistency in the acquisition of left ventricular...

Read more >
medical professionals conversing in hospital storage room office

June 19, 2019

MyoStrain's Economic Benefits in the Diagnosis and Management of Heart Failure Detailed in New Health Economics Review

A new article demonstrating the significant cost savings that could be achieved using MyoStrain to detect and manage early heart failure was published in Health Economics Review. The article, authored by Avalon Health Economics (Avalon), compares MyoStrain to Echocardiography (ECHO), the most...

Read more >